Indivior tumbles on falling sales forecast

Indivior

20/02/2025 08:37

** Shares of drugmaker Indivior  INDV.L  down 22.2% at 675
p, lowest since October 24
    ** London-listed co expects 2025 net revenue to decline 17%
at midpoint between $955 million and $1,025 million
    ** Co expects more than 50% fall in sales rev for Suboxone
Film due to intensified generic pricing activity and potential
fifth generic entrant   
    ** Co sees net revenue for key drug, SUBLOCADE, largely
unchanged, at midpoint between $725m to $765m 
    ** INDV expects adjusted operating profit between $185
million to $225 million in 2025
    ** In 2024, shares fell by 13.6%




 (
 Reporting by Simone Lobo in Bengaluru)
 ((Simone.Lobo@thomsonreuters.com; +919920570373;))